According to CNBC, JPMorgan initiated coverage of MSG Rangers with an overweight rating and set a $310 price target, implying 25% upside from Thursday’s close. Analyst David Karnovsky said shares traded at an approximately 30% discount to private-market value estimates, which he said may be understated. He cited limited team supply, growing ownership capital, media-rights trends and venue economics as factors supporting professional team valuations. Karnovsky also said a potential minority stake sale could provide a higher reference price for the team and fund operations and capital returns. Other potential catalysts he cited included NHL U.S. media-rights negotiations, team expansion and improved on-ice performance. MSG Rangers and MSG Knickerbockers became separate publicly traded firms in October. The stock is up 14% month to date, and all five analysts covering it have a buy or strong buy rating, according to LSEG data.